dupilumab CIU
Selected indexed studies
- Chronic Urticaria. (, 2026) [PMID:32310370]
- Combined use of Omalizumab and dupilumab: safety and efficacy data from a large academic center. (Arch Dermatol Res, 2025) [PMID:40186636]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.